US Stock MarketDetailed Quotes
PYXS Pyxis Oncology
- 3.750
- +0.520+16.10%
Close Oct 18 16:00 ET
- 3.690
- -0.060-1.60%
Post 19:54 ET
222.84MMarket Cap-2952P/E (TTM)
3.790High3.230Low1.67MVolume3.260Open3.230Pre Close5.94MTurnover4.28%Turnover RatioLossP/E (Static)59.42MShares6.85052wk High1.31P/B146.45MFloat Cap1.35052wk Low--Dividend TTM39.05MShs Float19.000Historical High--Div YieldTTM17.34%Amplitude1.100Historical Low3.559Avg Price1Lot Size
Pyxis Oncology Key Stats
Quarterly+Annual
YOY
| (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q4)Dec 31, 2022 | (Q3)Sep 30, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow (Indirect Method) | ||||||||||
| Cash flow from continuing operating activities | 72.74%-3.01M | 22.84%-20.71M | 20.85%-70.71M | 12.27%-15.25M | 14.47%-17.58M | 53.48%-11.03M | 3.03%-26.84M | -152.89%-89.34M | -42.88%-17.39M | -182.07%-20.56M |
| Net income from continuing operations | -8.80%-17.3M | 83.08%-3.26M | 38.87%-73.79M | 56.80%-15.6M | 16.71%-23.05M | 37.79%-15.9M | 38.68%-19.24M | -58.89%-120.72M | -114.52%-36.1M | -95.23%-27.67M |
| Depreciation and amortization | 11.64%585K | 487.37%1.12M | 171.79%1.93M | 259.38%690K | 161.50%523K | 229.56%524K | 20.25%190K | 9.58%709K | 21.52%192K | 25.79%200K |
| Other non cash items | -2.29%171K | 13.89%164K | -93.66%660K | -98.04%187K | -49.84%154K | -44.62%175K | -37.93%144K | -49.49%10.41M | 6,023.72%9.55M | 100.65%307K |
| Change In working capital | 597.84%12.3M | -78.28%-21.77M | -359.14%-11.66M | -145.51%-2.31M | -49.56%1.09M | 166.83%1.76M | -13,027.96%-12.21M | -32.58%4.5M | 515.41%5.07M | -41.72%2.16M |
| -Change in receivables | ---- | ---8M | ---- | ---- | ---- | ---- | --0 | ---- | ---- | ---- |
| -Change in prepaid assets | 961.46%2.04M | -520.99%-2.05M | 174.89%2.53M | 126.89%820K | 200.39%1.03M | -79.35%192K | 309.48%486K | -38.34%-3.38M | -89.61%-3.05M | -165.46%-1.03M |
| -Change in payables and accrued expense | 318.55%2.37M | 74.99%-3.51M | -585.90%-17.6M | -174.76%-3.31M | -129.50%-832K | 113.25%566K | -2,277.95%-14.03M | -62.78%3.62M | -25.68%4.43M | -33.68%2.82M |
| -Change in other current liabilities | -110.35%-104K | -141.47%-552K | -43.41%2.41M | -107.78%-287K | -2.70%361K | 176.86%1.01M | 906.67%1.33M | 792.52%4.26M | 204.56%3.69M | 337.82%371K |
| -Change in other working capital | --0 | ---7.66M | --998K | --471K | ---- | ---- | ---- | ---- | ---- | ---- |
| Cash from discontinued investing activities | ||||||||||
| Operating cash flow | 72.74%-3.01M | 22.84%-20.71M | 20.85%-70.71M | 12.27%-15.25M | 14.47%-17.58M | 53.48%-11.03M | 3.03%-26.84M | -152.89%-89.34M | -42.88%-17.39M | -182.07%-20.56M |
| Investing cash flow | ||||||||||
| Cash flow from continuing investing activities | 100.02%4K | 81.39%-18.5M | -1,538.52%-104.85M | 650.48%10.23M | 254.03%6.57M | -17,151.94%-22.26M | -67,977.40%-99.39M | -984.58%-6.4M | -1.86M | -4.27M |
| Net PPE purchase and sale | --0 | 94.62%-237K | -5.11%-6.73M | --0 | 98.57%-61K | -1,651.16%-2.26M | -2,917.81%-4.41M | -1,085.00%-6.4M | ---1.86M | ---4.27M |
| Net business purchase and sale | ---- | ---- | --6.66M | --1K | ---- | ---- | ---- | --0 | --0 | ---- |
| Net investment purchase and sale | 100.02%4K | 80.78%-18.26M | ---104.78M | --10.23M | ---27K | ---20M | ---94.99M | --0 | --0 | --0 |
| Cash from discontinued investing activities | ||||||||||
| Investing cash flow | 100.02%4K | 81.39%-18.5M | -1,538.52%-104.85M | 650.48%10.23M | 254.03%6.57M | -17,151.94%-22.26M | -67,977.40%-99.39M | -984.58%-6.4M | ---1.86M | ---4.27M |
| Financing cash flow | ||||||||||
| Cash flow from continuing financing activities | -98.20%110K | 57.51M | 3,139.89%5.93M | -25K | -2,950.00%-171K | 612,400.00%6.13M | 0 | -99.94%183K | 0 | 100.35%6K |
| Net common stock issuance | --0 | --57.46M | --6.12M | --0 | --0 | --6.12M | --0 | --0 | --0 | --0 |
| Proceeds from stock option exercised by employees | 5,000.00%153K | --245K | 37.70%252K | --27K | 3,600.00%222K | 200.00%3K | --0 | 9.58%183K | --0 | -57.14%6K |
| Net other financing activities | ---43K | ---196K | ---445K | ---52K | ---- | ---- | ---- | ---- | ---- | ---- |
| Cash from discontinued financing activities | ||||||||||
| Financing cash flow | -98.20%110K | --57.51M | 3,139.89%5.93M | ---25K | -2,950.00%-171K | 612,400.00%6.13M | --0 | -99.94%183K | --0 | 100.35%6K |
| Net cash flow | ||||||||||
| Beginning cash position | -46.01%29.44M | -93.84%11.14M | -34.58%180.77M | -91.91%16.19M | -87.83%27.37M | -78.07%54.53M | -34.58%180.77M | 3,274.65%276.32M | 49.72%200.01M | 57.68%224.83M |
| Current changes in cash | 89.35%-2.89M | 114.50%18.3M | -77.53%-169.63M | 73.75%-5.05M | 54.94%-11.18M | -13.93%-27.16M | -356.56%-126.23M | -135.64%-95.55M | -113.48%-19.25M | -175.87%-24.82M |
| End cash Position | -3.01%26.55M | -46.01%29.44M | -93.84%11.14M | -93.84%11.14M | -91.91%16.19M | -87.83%27.37M | -78.07%54.53M | -34.58%180.77M | -34.58%180.77M | 49.72%200.01M |
| Free cash flow | 77.37%-3.01M | 32.96%-20.95M | 19.11%-77.44M | 20.74%-15.25M | 28.92%-17.64M | 44.26%-13.29M | -12.30%-31.25M | -166.92%-95.73M | -58.15%-19.25M | -240.60%-24.82M |
| Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | -- | -- | Unqualified Opinion | -- | -- | -- | -- | Unqualified Opinion | -- | -- |
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
% Chg
No Data
